Boeing’s Recovery Path Remains Long Despite Better Factory Performance
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
AbbVie Says Qulipta Outperformed Topiramate in Phase 3 Trial
AbbVie reported that Qulipta outperformed topiramate in a Phase 3 migraine prevention trial.
L impact | EQUITY | Oct 29, 2026, 10:06 AM UTC
L3Harris Q3 Revenue Reaches $6.1 Billion, Above Estimate
L3Harris reported Q3 revenue of $6.1 billion, versus an IBES estimate of $5.913 billion.
M impact | EQUITY | Oct 29, 2026, 10:05 AM UTC
CRH Announces Share Buyback Program of Up to $6 Billion
CRH announced a new share buyback program of up to $6 billion, expiring at the end of 2030.
M impact | EQUITY | Oct 29, 2026, 10:05 AM UTC
Yirui Technology Says Q3 Revenue Rose 71.9% Year Over Year
M impact | EQUITY | Oct 29, 2026, 10:05 AM UTC
Xcel Energy reports third-quarter revenue of $4.17 billion
M impact | EQUITY | Oct 29, 2026, 10:05 AM UTC
HIVE Digital Technologies Secures $129M Financing for AI GPU Cluster
HIVE announced approximately $129 million in three-year financing to fund a sovereign AI GPU cluster for a previously announced customer contract.
M impact | EQUITY | Oct 29, 2026, 10:05 AM UTC